Prognostic Significance of Further Axillary Dissection in Breast Cancer Patients with Micrometastases & the Number of Micrometastases: a SEER Population-Based Analysis

References

• Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology Guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. 23(30), 7703 (2005).
   Google Scholar
• Giuliano AE, Mccall L, Beitsch P et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann. Surg. 252(3), 426–432; discussion 432–423 (2010).
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Hunt KK, Ballman KV et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6), 569 (2011).
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Ballman KV, Mccall L et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318(10), 918–926 (2017).
   PubMed Web of Science ®Google Scholar
• Latosinsky S, Berrang TS, Cutter CS et al. CAGS and ACS Evidence Based Reviews in Surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Can. J. Surg. 55(1), 66–69 (2012).
   PubMed Web of Science ®Google Scholar
• Caudle AS, Hunt KK, Kuerer HM et al. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann. Surg. Oncol. 18(9), 2407–2412 (2011).
   PubMed Web of Science ®Google Scholar
• Andersson Y, Frisell J, Sylvan M, De Boniface J, Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J. Clin. Oncol. 28(17), 2868–2873 (2010).
   PubMed Web of Science ®Google Scholar
• Boer MD, Deurzen CV, Dijck JV et al. Micrometastases and isolated tumor cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists’ group (BOOG). Cancer Res. 69(Suppl. 2), 23 (2009).
   PubMed Web of Science ®Google Scholar
• Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann. Surg. Oncol. 14(12), 3378–3384 (2007).
   PubMed Web of Science ®Google Scholar
• Gobardhan PD, Elias SG, Madsen EV et al. Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann. Surg. Oncol. 18(6), 1657–1664 (2011).
   PubMed Web of Science ®Google Scholar
• Ozao-Choy J, Giuliano AE. Prognostic significance of micrometastasis and isolated tumor cells in the sentinel lymph node. Breast Cancer Res. Treat. 127(1), 205–206 (2011).
   PubMed Web of Science ®Google Scholar
• Houvenaeghel G, Classe JM, Garbay JR et al. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study. Breast 23(5), 561–566 (2014).
   PubMed Web of Science ®Google Scholar
• Wasif N, Ye X, Giuliano AE. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty. Ann. Surg. Oncol. 16(9), 2442–2449 (2009).
   PubMed Web of Science ®Google Scholar
• Langer I, Guller U, Berclaz G et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann. Surg. 245(3), 452–461 (2007).
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Hansen NM et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J. Clin. Oncol. 27(18), 2946–2953 (2009).
   PubMed Web of Science ®Google Scholar
• Yi M, Giordano SH, Meric-Bernstam F et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann. Surg. Oncol. 17(Suppl. 3), 343–351 (2010).
   PubMedGoogle Scholar
• Galimberti V, Cole BF, Zurrida S et al. IBCSG 23-01 randomised controlled trial comparing axillary dissection versus no axillary dissection in patients with sentinel node micrometastases. Lancet Oncol. 14(4), 297 (2013).
   PubMed Web of Science ®Google Scholar
• Wang J, Mittendorf EA, Sahin AA et al. Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS ONE 9(2), e89778 (2014).
   PubMed Web of Science ®Google Scholar
• Wong SM, Freedman RA, Stamell E et al. Modern trends in the surgical management of Paget's disease. Ann. Surg. Oncol. 22(10), 3308–3316 (2015).
   PubMed Web of Science ®Google Scholar
• Wu Q, Li J, Sun S et al. Breast carcinoma in situ: an observational study of tumor subtype, treatment and outcomes. Oncotarget 8(2), 2361 (2016).
   Google Scholar
• Schmocker RK, Caretta-Weyer H, Weiss JM et al. Determining breast cancer axillary surgery within the surveillance epidemiology and end results – Medicare database. J. Surg. Oncol. 109(8), 756–759 (2014).
   PubMed Web of Science ®Google Scholar
• Tvedskov TF, Jensen MB, Ejlertsen B, Christiansen P, Balslev E, Kroman N. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study. Breast Cancer Res. Treat. 153(3), 599–606 (2015).
   PubMed Web of Science ®Google Scholar
• Sola M, Alberro JA, Fraile M et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Ann. Surg. Oncol. 20(1), 120–127 (2013).
   PubMed Web of Science ®Google Scholar
• Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Eur. J. Surg. Oncol. 39(6), 601–607 (2013).
   PubMed Web of Science ®Google Scholar
• Pernas S, Gil M, Benítez A et al. Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence. Ann. Surg. Oncol. 17(3), 772–777 (2009).
   Web of Science ®Google Scholar
• Tvedskov TF, Jensen MB, Lisse IM, Ejlertsen B, Balslev E, Kroman N. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node. Int. J. Cancer 131(10), 2367–2375 (2012).
   PubMed Web of Science ®Google Scholar
• Collins M, O'donoghue C, Sun W et al. Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer. J. Surg. Res. 215, 55–59 (2017).
   PubMed Web of Science ®Google Scholar
• Galimberti V, Botteri E, Chifu C et al. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res. Treat. 131(3), 819–825 (2012).
   PubMed Web of Science ®Google Scholar
• Youssef MM, Cameron D, Pucher PH, Olsen S, Ferguson D. The significance of sentinel lymph node micrometastasis in breast cancer: comparing outcomes with and without axillary clearance. Breast 30, 101–104 (2016).
   PubMed Web of Science ®Google Scholar
• Houvenaeghel G, Boher JM, Reyal F et al. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes. Eur. J. Cancer 67, 106–118 (2016).
   PubMed Web of Science ®Google Scholar
• Pepels MJ, De Boer M, Bult P et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann. Surg. 255(1), 116–121 (2012).
   PubMed Web of Science ®Google Scholar
• Azghadi S, Daly M, Mayadev J. Practice patterns of radiation field design for sentinel lymph node-positive early-stage breast cancer. Clin. Breast Cancer 16(5), 410e413–417e413 (2016).
   Web of Science ®Google Scholar
• Mamtani A, Patil S, Van Zee KJ et al. Age and receptor status do not indicate the need for axillary dissection in patients with sentinel lymph node metastases. Ann. Surg. Oncol. 23(11), 3481–3486 (2016).
   PubMed Web of Science ®Google Scholar
• De Boer M, Van Deurzen CHM, Van Dijck JaaM et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N. Engl. J. Med. 361(7), 653 (2009).
   PubMed Web of Science ®Google Scholar
• Onishi T, Jinno H, Takahashi M et al. Non-sentinel lymph node status and prognosis of breast cancer patients with micrometastatic sentinel lymph nodes. Eur. Surg. Res. 45(3–4), 344–349 (2010).
   PubMed Web of Science ®Google Scholar
• Bargehr J, Edlinger M, Hubalek M, Marth C, Reitsamer R. Axillary lymph node status in early-stage breast cancer patients with sentinel node micrometastases (0.2–2 mm). Breast Care (Basel) 8(3), 187–191 (2013).
   PubMed Web of Science ®Google Scholar
• Mamtani A, Patil S, Stempel M, Morrow M. Axillary micrometastases and isolated tumor cells are not an indication for post-mastectomy radiotherapy in stage 1 and 2 breast cancer. Ann. Surg. Oncol. 24(8), 2182–2188 (2017).
   PubMed Web of Science ®Google Scholar
• Kumar S, Bramlage M, Jacks LM et al. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease. Ann. Surg. Oncol. 17(11), 2909–2919 (2010).
   PubMed Web of Science ®Google Scholar
• Truong PT, Vinh-Hung V, Cserni G et al. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur. J. Cancer 44(12), 1670–1677 (2008).
   PubMed Web of Science ®Google Scholar
• Dillon MF, Hayes BD, Quinn CM et al. The extent of axillary lymph node clearance required following detection of sentinel node micrometastases. Breast J. 16(5), 533–536 (2010).
   PubMed Web of Science ®Google Scholar